CIBC Private Wealth Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
JGCM
MWM
DBIA
CIBC Private Wealth Group's PJP Position: Q4 2025 in Review
CIBC Private Wealth Group held its Invesco Pharmaceuticals ETF (PJP) position steady in Q4 2025 at 2,200 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.
CIBC Private Wealth Group first reported a position in PJP in Q1 2017 and has held it in 18 quarters since. The position peaked at $3.61M in Q3 2018. 105 funds tracked by Wall St. Rank hold PJP as of Q4 2025.
- CIBC Private Wealth Group held 2,200 shares of Invesco Pharmaceuticals ETF worth $230K as of Q4 2025.
- CIBC Private Wealth Group left its Invesco Pharmaceuticals ETF share count unchanged in Q4 2025.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1131 holding.
- CIBC Private Wealth Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and has held it in 18 quarters since.
- CIBC Private Wealth Group's Invesco Pharmaceuticals ETF position peaked at $3.61M in Q3 2018.
- 105 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.